iBio, Inc. (IBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Annual

0 900K 1.8M 2.7M FY11: 520.1K FY12: 1.3M FY13: 1M FY14: 205K FY15: 1.9M FY16: 948K FY17: 394K FY18: 444K FY19: 2M FY20: 1.6M FY21: 2.4M FY22: 1.9M FY23: 0 FY24: 225K FY25: 400K FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 800K 1.6M 2.4M FY20: 935K FY21: 909K FY22: 2.2M FY20 FY21 FY22

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY11: -9.7M FY12: -9.3M FY13: -6.7M FY14: -3.8M FY15: -6.7M FY16: -9.9M FY17: -14.3M FY18: -14.2M FY19: -15.8M FY20: -14M FY21: -31.1M FY22: -29.7M FY23: -29.3M FY24: -16.6M FY25: -18.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-75M -50M -25M 0 25M 50M 75M FY11: -12.1M FY12: -5.7M FY13: -6.2M FY14: -3.7M FY15: -6.6M FY16: -9.8M FY17: -14.5M FY18: -16.1M FY19: -17.6M FY20: -16.4M FY21: -23.2M FY22: -50.3M FY23: -65M FY24: -24.9M FY25: -18.4M FY26: -32.8M FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Cost of Revenue Annual

0 500K 1M 1.5M FY20: 703K FY21: 1.5M FY22: 216K FY20 FY21 FY22

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY11: -5.3M FY12: -6M FY13: -4.8M FY14: -4.1M FY15: -4.7M FY16: -8.1M FY17: -13.2M FY18: -13.5M FY19: -14M FY20: -13.3M FY21: -30.1M FY22: -37.5M FY23: -30.4M FY24: -18.6M FY25: -15.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY11: -5.3M FY12: -6M FY13: -4.9M FY14: -4.1M FY15: -4.7M FY16: -8.1M FY17: -14.5M FY18: -14.4M FY19: -14.9M FY20: -14.4M FY21: -35M FY22: -44.8M FY23: -36.2M FY24: -18.8M FY25: -15.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 4M 8M 12M FY21: 7.8M FY22: 8.7M FY23: 612K FY24: 3.8M FY25: 10.5M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q4 '11: -0.38 Q1 '12: -0.27 Q2 '12: -0.17 Q3 '12: -0.15 Q4 '12: -0.13 Q1 '13: -0.18 Q2 '13: -0.15 Q3 '13: -0.12 Q4 '13: -0.13 Q1 '14: -0.08 Q2 '14: -0.09 Q3 '14: -0.07 Q4 '14: -0.06 Q1 '15: -0.09 Q2 '15: -0.08 Q3 '15: -0.08 Q4 '15: -0.08 Q1 '16: -0.08 Q2 '16: -0.09 Q3 '16: -0.11 Q4 '16: -0.12 Q1 '17: -0.13 Q2 '17: -0.14 Q3 '17: -0.14 Q4 '17: -1.64 Q1 '18: -2.03 Q2 '18: -2.40 Q3 '18: -2.71 Q4 '18: -1.56 Q1 '19: -1.39 Q2 '19: -1.22 Q3 '19: -1.09 Q4 '19: -0.94 Q1 '20: -0.90 Q2 '20: -1.35 Q3 '20: -1.19 Q4 '20: -0.61 Q1 '21: -0.45 Q2 '21: 0.20 Q3 '21: 0.22 Q4 '21: -3.01 Q1 '22: -5.36 Q2 '22: -6.69 Q3 '22: -8.07 Q4 '22: -7.15 Q1 '23: -6.80 Q2 '23: -73.86 Q3 '23: -83.51 Q4 '23: -76.46 Q1 '24: -79.21 Q2 '24: -15.20 Q3 '24: -4.98 Q4 '24: -6.50 Q1 '25: -2.16 Q2 '25: 1.78 Q3 '25: 2.14 Q4 '25: -1.74 Q1 '26: -1.39 Q2 '26: -1.00 Q3 '26: -0.57 Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.